These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22983960)

  • 1. Caring for children with drug-resistant tuberculosis: practice-based recommendations.
    Seddon JA; Furin JJ; Gale M; Del Castillo Barrientos H; Hurtado RM; Amanullah F; Ford N; Starke JR; Schaaf HS;
    Am J Respir Crit Care Med; 2012 Nov; 186(10):953-64. PubMed ID: 22983960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations.
    Garcia-Prats AJ; Rose PC; Hesseling AC; Schaaf HS
    Tuberculosis (Edinb); 2014 Mar; 94(2):93-104. PubMed ID: 24388605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis in childhood.
    Shingadia D
    Ther Adv Respir Dis; 2012 Jun; 6(3):161-71. PubMed ID: 22361927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric use of second-line anti-tuberculosis agents: a review.
    Seddon JA; Hesseling AC; Marais BJ; McIlleron H; Peloquin CA; Donald PR; Schaaf HS
    Tuberculosis (Edinb); 2012 Jan; 92(1):9-17. PubMed ID: 22118883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians.
    Schaaf HS; Marais BJ
    Paediatr Respir Rev; 2011 Mar; 12(1):31-8. PubMed ID: 21172673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities.
    Lienhardt C; Davies G
    Int J Tuberc Lung Dis; 2010 May; 14(5):528-37. PubMed ID: 20392344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-resistant tuberculosis: pediatric guidelines.
    Al-Dabbagh M; Lapphra K; McGloin R; Inrig K; Schaaf HS; Marais BJ; Sauve L; Kitai I; Kollmann TR
    Pediatr Infect Dis J; 2011 Jun; 30(6):501-5. PubMed ID: 21297522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hearing loss in patients on treatment for drug-resistant tuberculosis.
    Seddon JA; Godfrey-Faussett P; Jacobs K; Ebrahim A; Hesseling AC; Schaaf HS
    Eur Respir J; 2012 Nov; 40(5):1277-86. PubMed ID: 22700838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric tuberculosis: new guidelines and recommendations.
    Perez-Velez CM
    Curr Opin Pediatr; 2012 Jun; 24(3):319-28. PubMed ID: 22568943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis.
    O'Grady J; Maeurer M; Mwaba P; Kapata N; Bates M; Hoelscher M; Zumla A
    Curr Opin Pulm Med; 2011 May; 17(3):134-41. PubMed ID: 21415753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of multidrug-resistant tuberculosis: an update.
    Monedero I; Caminero JA
    Ther Adv Respir Dis; 2010 Apr; 4(2):117-27. PubMed ID: 20388724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
    Yew WW
    Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 17. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of multi-drug resistant tuberculosis: practitioner's view point.
    Prasad R
    Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of drug-resistant tuberculosis.
    Chiang CY; Schaaf HS
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):672-82. PubMed ID: 20487603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
    Ahmad S; Mokaddas E
    Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.